Monday, September 14, 2026

From R&D to Global Blockbuster: Fexuclue Sparks a New Vision for Daewoong

Daewoong Pharmaceutical's Fexuclue achieves rapid success with innovative marketing and aims for significant growth in treating GERD.

Failure to Launch: North Korea’s Missile Explodes Mid-Air…Again

Korea conducted a confirmed test launch of...

New Drug Candidate Shows Promise Against Solid Tumors by Eliminating M2 Macrophages

Researchers have developed a peptide drug that targets M2 macrophages, enhancing solid tumor immunotherapy effectiveness.

Tag: EADV

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Celltrion’s ‘Psoriasis’ Biosimilar Poised to Challenge Big Pharma with Phase 1 Data

The EADV conference in Paris showcased Celltrion's biosimilar CT-P55, confirming its equivalence to Cosentyx in safety and pharmacokinetics.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.